Prof Maria Paola Costi talks to ecancer at the 4th EUTROC meeting in Liverpool, UK about new drug developments and the main issues surrounding the drug approval process for ovarian cancer. She highlights work being done on folate receptors and their role in ovarian cancer; in particular, a project discussed at the meeting on candidate drugs targeting this receptor and the difficulty of advancing these drugs to the clinical stages.
Drug approval process for ovarian cancer / Costi, Maria Paola. - ELETTRONICO. - 15-11-2012(2012).
I documenti presenti in Iris Unimore sono rilasciati con licenza Creative Commons Attribuzione - Non commerciale - Non opere derivate 3.0 Italia, salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris